Stephens Inc’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Stephens Inc’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,794	Closed	-$1.04M	–	1392
2021 Q1	$1.04M	Sell	4,794 -164	-3%	-$30.8K	0.02%	610
2020 Q4	$572K	Buy	4,958 +2,108	+74%	+$236K	0.01%	735
2020 Q3	$277K	Buy	2,850 +573	+25%	+$65.9K	0.01%	916
2020 Q2	$279K	Sell	2,277 -300	-12%	-$34K	0.01%	862
2020 Q1	$226K	Sell	2,577 -540	-17%	-$57.2K	0.01%	854
2019 Q4	$326K	Sell	3,117 -40	-1%	-$4.49K	0.01%	842
2019 Q3	$363K	Buy	3,157 +490	+18%	+$74.4K	0.01%	847
2019 Q2	$460K	Buy	2,667 +10	+0.4%	+$1.73K	0.01%	770
2019 Q1	$448K	Sell	2,657 -3,369	-56%	-$501K	0.01%	787
2018 Q4	$587K	Buy	+6,026	New	+$791K	0.02%	659

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Stephens Inc's GWPH Position: Q2 2021 in Review

Stephens Inc sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,794 shares — an estimated $1.04M sold.

Stephens Inc first reported a position in GWPH in Q4 2018 and held it in 10 quarters. The position peaked at $1.04M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Stephens Inc reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Stephens Inc sold 4,794 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.04M.
Stephens Inc first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
Stephens Inc's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.04M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Stephens Inc's 13F filing for Q2 2021, filed 12 Aug 2021.